Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-11-01

Clinical Trial Update: Turmeric Effect on Reduction of Serum Prolactin and Related Hormonal Change and Adenoma Size in Prolactinoma Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating turmeric's effect on serum prolactin levels and adenoma size in prolactinoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Turmeric (turmeric)

Snippet

Sponsor: Mashhad University of Medical Sciences | Conditions: Hyperprolactinoma | Phase 1 | Status: UNKNOWN